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ABSTRACT 
Background: Evidence suggests that individualised exercise-based cardiac 
rehabilitation should be offered to patients with ischemic heart disease and chronic 
heart failure (HF) because it improves physical fitness and health-related quality of 
life (HR-QoL), and reduces cardiac mortality and hospital admissions. If 
physiotherapist-led exercise-based cardiac rehabilitation (PT-X) can similarly 
improve physical fitness in patients with atrial fibrillation (AF), and improve 
physical activity levels in patients with chronic HF or permanent AF, has been 
sparsely studied. In addition, whether increased physical activity in patients with 
chronic HF or permanent AF can improve physical fitness in the same way as 
exercise has not been evaluated. 
Aim: The general aim for this thesis was to investigate the effect of individually 
prescribed PT-X in elderly patients with chronic HF or permanent AF especially in 
regards to exercise modality, physical fitness, level of physical activity, HR-QoL, 
and metabolic risk factors. 
Method and Main Findings: Study I. A randomised controlled trial (RCT) in 
patients with chronic HF and comorbidity investigating the effect of PT-X regarding 
the level of physical activity, physical fitness (i.e., exercise capacity and muscle 
function), and HR-QoL. Physical activity did not increase significantly after PT-X, 
though self-reported physically activity levels were higher. Physical fitness and HR-
QoL improved significantly in the PT-X group compared to the control group. Study 
II. A RCT multicentre trial comparing PT-X and physical activity on prescription 
(PAP) with regard to physical fitness, level of physical activity, HR-QoL and 
metabolic risk markers in patients with permanent AF. Physical fitness improved 
significantly in PT-X compared to PAP. PAP increased energy expenditure but not 
physical fitness. No significant difference was found in HR-QoL or metabolic risk 
markers. Study III. A 3-month follow-up of study II investigating the effect of 3 
months detraining with respect to physical fitness, level of physical activity, and HR-
QoL in patients with permanent AF. The improvements achieved in physical fitness 
in the PT-X group decreased significantly with detraining, and HR-QoL was 
markedly reduced. 
Conclusion: PT-X is well tolerated and safe and, therefore, should be used to 
improve physical fitness in patients with chronic HF or permanent AF. Neither PT-X 
nor PAP increases the physical activity level. PT-X improves HR-QoL in patients 
with chronic HF but not in patients with permanent AF. In patients with permanent 
AF, it is important to continue exercising because detraining reverses the gains in 
physical fitness obtained from PT-X and markedly decreases HR-QoL.     
Keywords: exercise-based cardiac rehabilitation, exercise, physical fitness, physical 
activity, health-related quality of life, atrial fibrillation, heart failure.                    
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SAMMANFATTNING PÅ SVENSKA 
Evidensen visar att individanpassad fysisk träning inom hjärtrehabilitering ska 
erbjudas samtliga patienter med ischemisk hjärtsjukdom och kronisk hjärtsvikt (HF), 
då det förbättrar fysisk kapacitet, hälsorelaterad livskvalitet (HR-QoL) samt minskar 
risken för kardiell mortalitet och antalet vårdtillfällen på sjukhus. Om fysioterapeut-
ledd fysisk träning inom hjärtrehabilitering (PT-X) kan förbättra fysisk kapacitet hos 
patienter med förmaksflimmer (AF) på liknande sätt, och om PT-X kan öka den 
fysiska aktivitetsnivån hos patienter med kronisk HF är sparsamt studerat. I tillägg, är 
det inte utvärderat huruvida en ökad fysisk aktivitetsnivå hos patienter med kronisk 
HF eller permanent AF påverkar fysisk kapacitet positivt på samma vis som fysisk 
träning.                                                                               
Syfte: Det övergripande syftet med avhandlingen var att undersöka effekterna av PT-
X hos patienter med kronisk HF eller permanent AF med speciell referens till 
träningsform, fysisk kapacitet, fysisk aktivitetsnivå, HR-QoL och metabola 
riskmarkörer.                                                               
Metod och huvudresultat: Studie I. En randomiserad kontrollerad studie (RCT) 
undersökte effekten av PT-X avseende fysisk aktivitetsnivå, fysisk kapacitet 
(arbetskapacitet och muskelfunktion) och HR-QoL hos patienter med kronisk HF och 
samtidig medsjuklighet. Fysisk aktivitetsnivå ökade inte signifikant efter PT-X även 
om patienterna skattade sig mer aktiva. Fysisk kapacitet och HR-QoL förbättrades 
med PT-X jämfört med kontrollgruppen. Studie II. En RCT multicenterstudie 
jämförde PT-X och fysisk aktivitet på recept (PAP) avseende fysisk kapacitet, fysisk 
aktivitetsnivå, HR-QoL och metabola riskmarkörer hos patienter med permanent AF. 
Fysisk kapacitet förbättrades signifikant i gruppen som erhöll PT-X jämfört med 
PAP. Gruppen som erhöll PAP ökade sin energiförbrukning men inte fysisk 
kapacitet. Studie III. En 3 månaders uppföljning av studie II, undersökte effekten av 
3 månaders träningsuppehåll avseende fysisk kapacitet, fysisk aktivitetsnivå och HR-
QoL hos patienter med permanent AF. Förbättringarna avseende fysisk kapacitet som 
erhållits med PT-X var signifikant försämrade efter träningsuppehållet och HR-QoL 
var märkbart reducerad.      
 Konklusion: PT-X är väl tolererat och säkert och bör därför förskrivas till patienter 
med kronisk HF och permanent AF. Varken PT-X eller PAP ökar fysiska 
aktivitetsnivåer. PT-X förbättrar HR-QoL hos patienter med kronisk HF men inte hos 
patienter med permanent AF. Hos patienter med permanent AF är det viktigt att 
vidmakthålla träning då träningsuppehåll reducerar den förbättring av fysisk 
kapacitet som erhållits av PT-X och märkbart försämrar HR-QoL.  
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ABBREVIATIONS 
ACT Aerobic continuous exercise training 
AF Atrial fibrillation 
AIT Aerobic interval exercise training 
ATP Adenosine triphosphate 
a-vO2 
difference 
Arteriovenous oxygen difference 
CAD Coronary artery disease 
CO Cardiac output 
CR Cardiac rehabilitation 
DBP Diastolic blood pressure 
ECG Electrocardiogram 
EF Ejection fraction  
HF Heart failure 
HR Heart rate 
HRR Heart rate reserve 
HR-QoL Health-related quality of life 
ITT Intention-to-treat analysis 
LV Left ventricle  
MET Metabolic equivalent of task 
NYHA  New York Heart Association  
PT-X Physiotherapist-led exercise-based cardiac rehabilitation   
vi 
PAP Physical activity on prescription 
RPE Rate of perceived exertion (Borg´s scale 6-20) 
SBP Systolic blood pressure 
SV Stroke volume 
TTE Trans-thoracic echocardiography 
VO2max Maximal rate of oxygen consumption 
VO2peak Peak rate of oxygen consumption 
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DEFINITIONS IN SHORT 
Aerobic Oxygen-requiring energy reactions (1) .  
Detraining “Partial or complete loss of training-induced 
anatomical, physiological, and performance 
adaptations as a consequence of training 
reduction or cessation” (2), or a “cessation 
(stopping) or reduction of training or a 
decrease in physical performance caused by 
a cessation or reduction in training” (3). 
Exercise 
 
 
 
“Physical activity that is planned, structured, 
repetitive, and purposive in the sense that 
improvement or maintenance of one or more 
components of physical fitness is an 
objective” (4). 
MET 1 MET corresponds to the resting metabolic 
rate. VO2 of 3.5 mL × kg-1 × min-1 (1) . 
NYHA classification Functional classification from I to IV based 
on symptom severity and the amount of 
exertion needed to provoke symptoms (5) . 
Physical activity “Any bodily movement produced by the 
skeletal muscles that results in energy 
expenditure” (4). 
Physical fitness A set of attributes that people have or 
achieve that relates to the ability to perform 
physical activity. Physical fitness can be 
either health-related physical fitness or 
skilled-related physical fitness (4). 
Physical inactivity An activity level insufficient to meet present 
recommendations (6). 
viii 
Relative intensity The percentage of maximal aerobic power, 
VO2max, HRmax  or HRR (1).  
VO2max Maximal oxygen uptake. The highest 
oxygen uptake achieved despite increases in 
exercise intensity (1). 
VO2peak Highest oxygen uptake achieved (1). 
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1 INTRODUCTION 
The evidence for cardiac rehabilitation (CR) in patients with chronic heart 
failure (HF) is high, (7) and has been given priority 3 in the recommendations 
issued by the National Board of Health and Welfare in Sweden (8). In the 
clinical setting, patients with chronic HF have the opportunity to participate 
in physiotherapist-led group-based exercise within their CR (PT-X). Despite 
the high level of evidence, the participation rate is remarkably low. 
According to RiksSvikt, in 2015, only 5% of patients participated in PT-X. 
The participation rate was age-dependent; only 1% of patients >75 years old 
participated in PT-X (9). For patients with atrial fibrillation (AF), the overall 
evidence for PT-X is low, (10) and it is considered an area of research and 
development by the National Board of Health and Welfare in Sweden (8). For 
patients with AF, PT-X is non-existent, and individually prescribed PT-X is 
rare. During the last decade, the amount of research regarding the health 
effects of physical activity has grown, showing that sufficiently high levels of 
physical activity in healthy individuals can postpone the development of 
lifestyle-related disease. Therefore, during the last two decades in Sweden, 
physical activity on prescription (PAP) has been widely used within health 
care for primary and secondary prevention of several diseases (11, 12). 
However, the method has not been evaluated for patients with cardiac 
diseases. This thesis investigates the concepts of exercise and physical 
activity in elderly patients with chronic HF and permanent AF, which are two 
of the most common cardiac diseases in the elderly population (13). Chronic 
HF and AF often co-exist, sharing the same predisposing risk factors (13, 14) 
and similar symptoms, such as low physical fitness, dyspnoea, and fatigue 
(15). For patients with chronic HF, exercise improves the general well-being 
and ability to maintain independent living (16).  
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1.1 Heart Failure and Atrial Fibrillation 
 Heart failure 
HF is a syndrome in which the heart fails to deliver oxygen and meet the 
metabolic requirements of the body tissues (17). HF is diagnosed in the 
presence of symptoms either during exertion or at rest and/or ankle swelling, 
together with objective evidence of cardiac dysfunction obtained by different 
imaging techniques, such as trans-thoracic echocardiography (TTE) (Table 1) 
(18). HF is usually accompanied by reduced cardiac output (CO) and/or 
elevated intracardiac pressure at rest and during exertion (18). The 
terminology includes HF with a left ventricular ejection fraction (LVEF) that 
is reduced (HFrEF), mid-range (HFmrEF), or preserved (HFpEF) (Table 2) 
(18). Congestive HF is a term that is sometimes used and may describe acute 
and chronic HF with evidence of volume overload (18). The severity of HF is 
described according to the New York Heart Association (NYHA) 
classification (Table 3) (5, 18). Chronic HF has a poor prognosis, with a 5-
year survival rate of ≈ 50% and an even poorer prognosis in those with the 
worst symptoms (19) and low physical fitness (20). Ischemic heart disease, 
hypertension, and valvular disease are the most common causes of HF in 
western high income countries (21). The prevalence of chronic HF in Sweden 
is approximately 2-3% (19, 22). Pharmacological treatment in patients with 
HF aims to improve longevity, functional capacity, and health-related quality 
of life (HR-QoL) (18). The treatment of a patient with chronic HF includes 
pharmacological treatment, nurse-led receptions, and PT-X (18).  
The pharmacological treatment includes beta-blockers, angiotensin-
converting enzyme inhibitors, and mineralocorticoid/aldosterone receptor 
antagonist, which has been shown to improve survival, and diuretics, which 
reduce signs and symptoms of congestion in patients with HFrEF (18). 
Electronic devices, such as cardiac resynchronisation therapy (CRT) and 
implantable cardioverter-defibrillators (ICDs), are beneficial for some 
patients (18). As a medical treatment, PT-X should be offered to medically 
stable patients with chronic HF in NYHA classification II and III (7). Patients 
with chronic HF usually have skeletal muscle abnormities, such as reduced 
muscle fibre type I, decreased number of capillaries per muscle fibre, and 
mitochondrial dysfunction, which all contribute to reduced physical fitness 
(20, 23). Secondary to skeletal muscle abnormalities, the ergo receptors in the 
skeletal muscle become more sensitive, which relates to the ventilator 
response, dyspnoea, and sympathetic overdrive (24, 25). Increased 
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inflammatory cytokines, especially tumour necrosis factor alpha (TNF-α) and 
interleukin 1β (IL-1 β), also play an important role in the alterations of 
skeletal muscles seen in chronic HF (20, 23).  
Table 1. Typical symptoms and signs of heart failure, described by 
Ponikowski et al (18). 
Typical symptoms of HF Specific signs of HF 
Breathlessness Elevated jugular pressure  
Orthopnoea Hepatojugular reflux 
Paroxysmal nocturnal dyspnoea Third heart sound 
Reduced exercise tolerance Lateral displaced apical impulse 
Fatigue, tiredness, increased time to 
recover after exercise 
 
Ankle swelling  
Less typical symptoms of HF Less specific signs of HF 
Nocturnal cough Weight gain (>2 kg/week) 
Wheezing Weight loss (in advanced HF) 
Bloated feeling Tissue wasting (cachexia) 
Loss of appetite Cardiac murmur 
Confusion (especially in the 
elderly) 
Peripheral oedema (ankle, sacral, scrotal) 
Depression Pulmonary crepitation 
Palpitations Reduced air entry and dullness to 
percussion in lung bases (pleural 
effusion) 
Dizziness Tachycardia 
Syncope Irregular pulse 
Bendopnea Tackypnoea 
 Cheyne-Stokes respiration 
 Hepatomegaly 
 Ascites 
 Cold extremities 
 Oliguria 
 Narrow pulse pressure 
HF: Heart failure.  
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Table 2. Definition of heart failure, described by Ponikowski et al (18).  
Criterion HFrEF HFmrEF HFpEF 
1 Symptoms ± signs* Symptoms ± signs* Symptoms ± signs* 
2 LVEF < 40% LVEF 40-49% LVEF ≥ 50% 
3  
 
1. Elevated levels of 
naturetic peptides 
2. At least one    
additional criterion:        
a. relevant structural 
heart disease (LVH 
and/or LAE).                  
b. diastolic       
dysfunction 
1. Elevated levels of 
naturetic peptides 
2. At least one 
additional criterion:         
a. relevant structural 
heart disease (LVH 
and/or LAE).           
b. diastolic 
dysfunction 
HF: Heart failure, HFrEF: Heart failure with reduced ejection fraction, HFmrEF: Heart failure with mid-
range ejection fraction, HFpEF: Heart failure with preserved ejection fraction, LAE: left atrial 
enlargement; LVEF: left ventricular ejection fraction; LVH: left ventricular hypertrophy. * Signs might 
not be present in the early stages of HF (especially in patients with HFpEF) or in patients treated with 
diuretics.  
 
 
Table 3. New York Heart Association functional classification. Adapted from 
the criteria committee of the New York Heart Association (5) .  
Class Description 
I No limitations on physical activity. Ordinary physical activity does 
not cause undue fatigue, palpitation or dyspnoea.  
II Slight limitation of physical activity. Comfortable at rest, but 
ordinary physical activity results in fatigue, palpitations, or dyspnoea. 
III Marked limitation of physical activity. Comfortable at rest, but less 
than ordinary physical activity causes fatigue, palpitations or 
dyspnoea.  
IV Unable to carry out any physical activity without discomfort. 
Symptoms of cardiac insufficiency at rest. If any physical activity is 
undertaken, discomfort is increased.  
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 Atrial fibrillation  
AF is the most common clinically significant arrhythmia in adults. AF is 
characterised by electrocardiogram (ECG) findings of irregular R-R intervals 
and an absence of distinct P waves. The chaotic atrial electrical activity in AF 
leads to a loss of atrial contraction and its contribution to ventricular diastolic 
filling (26, 27), as well as electrical and structural changes in the atria 
referred to as remodelling (26). The loss of atrial systole reduces stroke 
volume (SV) and, together with an irregular heart rate (HR), the CO (27). 
The HR is usually higher at rest than during sinus rhythm, and during 
exercise the HR increase is usually accelerated. The terminology includes 
five patterns of AF (Table 4) (28). The prevalence of AF in Sweden is 
approximately 3% in the adult population, but this may be underestimated 
(29). According to the Euro Heart survey, 30% of patients with AF are 
diagnosed with permanent AF (30). AF increases with age and is more 
common in men in each age group (29). The incidence of AF is expected to 
increase due to increasing longevity (31). AF is associated with a higher 
morbidity rate due to stroke (4-5 times increase) and HF (2-3 times increase) 
(28). The treatment of AF includes both acute and chronic management to 
reduce the risk of complications and alleviate symptoms (Table 5). 
Assessment of stroke risk and prevention by oral anticoagulation (65-70% 
risk reduction) is a major goal. Rate reduction and rhythm regulation are 
other goals to achieve haemodynamic stability and reduce symptoms. There 
is increasing awareness of the importance of managing precipitating factors, 
such as obesity and overconsumption of alcohol and nicotine, with lifestyle 
changes, as well as treatment of underlying cardiac and non-cardiac diseases, 
including hypertension and diabetes. Rate regulation reduces symptoms and 
the risk of tachycardia-induced HF, and is achieved by using beta-blockers, 
calcium channel antagonists (verapamil, diltiazem), and digitalis. For rhythm 
regulation, antiarrhythmic drugs, cardioversion, catheter ablation, and surgery 
for AF are alternatives (28). Several cardiovascular and other conditions are 
independently associated with AF, including hypertension, HF, valvular 
disease, myocardial infarction, thyroid dysfunction, obesity, diabetes 
mellitus, chronic obstructive lung disease, obstructive sleep apnoea, smoking, 
alcohol consumption, habitual vigorous exercise, and chronic kidney disease 
(28). Whether patients with AF have similar skeletal muscle abnormities as in 
chronic HF is unknown. However, patients with permanent AF have 
inspiratory muscle weakness (32), which suggests muscular alterations as one 
component of reduced physical fitness.  
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Table 4. Patterns of atrial fibrillation, described by Kirchhof et al (28).  
AF: Atrial fibrillation 
Table 5. Symptoms and signs of atrial fibrillation. Adapted from Riensta et al 
(33) and Morin et al (26). 
Symptoms of AF* Signs of AF on ECG 
Palpitations Presence of irregular RR intervals  
Chest pain Absence of distinct P-wave 
Reduced exercise capacity   
Dyspnoea  
Fatigue  
Dizziness  
AF: Atrial fibrillation, ECG: Electrocardiogram. *Approximately 15-30% of patients are asymptomatic. 
Asymptomatic AF is often discovered incidentally during population surveys or routine physical 
examinations. 
 
Type of AF Definition 
First detected AF AF that has not been diagnosed before, irrespective of the 
duration of the arrhythmia or the presence and severity of AF-
related symptoms. 
Paroxysmal AF Self-terminating, in most cases within 48 hours. Some AF 
paroxysms may continue for up to 7 days. AF episodes that are 
cardioverted within 7 days should be considered paroxysmal. 
Persistent AF AF that lasts longer than 7 days, including episodes that are 
terminated by cardioversion, either with drugs or by direct 
current cardioversion, after 7 days or more. 
Long-standing 
persistent AF 
Continuous AF lasting for ≥ 1 year when it is decided to adopt a 
rhythm control strategy. 
Permanent AF AF that is accepted by the patient (and physician). Hence, 
rhythm control interventions are, by definition, not pursued in 
patients with permanent persistent AF. Should a rhythm control 
strategy be adopted, the arrhythmia would be re-classified as 
long-standing 
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1.2 Exercise and Physical Activity 
This thesis is investigating the effect of the concepts exercise and physical 
activity (4) and their effects on physical fitness in patients with chronic HF 
and permanent AF. The concepts are defined in Figure 1. 
 Exercise 
Exercise is a subset of physical activity with the aim to improve or maintain 
one or more components of physical fitness (4). Exercise is not synonymous 
with physical activity, though it is sometimes used interchangeably. 
 Physical activity 
Insufficient levels of physical activity is a leading risk factor for global 
mortality (6). Physical activity includes activities such as work-related 
physical activity, playing, carrying out household chores, transportation, and 
engaging in recreational pursuits (4). Physical activity can be measured 
objectively as body movement, such as steps taken, swimming, and cycling. 
The intensity, frequency, and duration of physical activity, both indoor and 
outdoor, and the energy expenditure of the physical activity can also be 
measured objectively. It is also possible to measure time in sleep and time 
spent sitting, though this is not physical activity. Furthermore, the patients’ 
perceived level of physical activity can be assessed by questionnaires. These 
questionnaires include the patients’ perceived intensity, frequency, and 
duration of physical activity. Measurements of physical activity are also often 
accompanied by a physical activity diary, which is used as a log for the 
performed physical activity. Different kinds of physical activity can be 
calculated as metabolic equivalents of task (METs) to determine the energy 
expenditure for the performed physical activity (34).  
In this thesis, physical activity is measured both subjectively and objectively. 
In study I, the International Physical Activity Questionnaire (IPAQ) was used 
to subjectively measure physical activity together with a pedometer 
measuring steps per day. In studies II and III, the IPAQ was used together 
with an accelerometer to measure steps, the intensity of physical activity, and 
energy expenditure. These measurements are described under the Methods 
section. 
The recommended levels of physical activity for adults are presented in Table 
6 (35, 36).  
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The physical activity should be performed in bouts ≥ 10 minutes (36). Those 
who do not live up to the recommended levels of physical activity are 
inactive. Physical inactivity has recently been defined as “an activity level 
insufficient to meet present recommendations” (6). 
If an older adult cannot perform the recommended amount of physical 
activity due to health conditions, they should be as physically active as their 
abilities and conditions allow (35) . Whether less physical activity than stated 
in the guidelines will benefit the prognosis of people living with chronic HF 
has not yet been studied (37).  
Table 6. Recommended levels of physical activity.  
RPE: Rating of perceived exertion, Borg scale 6-20, * Aerobic moderate and vigorous physical activity 
could be performed separately or in combination.  
 
 
 
Aerobic physical activity 
Frequency Intensity RPE  Duration/week  
Most days of            
the week 
12-13 *   150 min 
 14-17*  75 min 
Muscle-strengthening activities 
Frequency,   
times/week  
Intensity RPE Major muscle groups, 
number of exercises  
Number of 
repetitions 
≥ 2   ≥ 15 8-10 8-12 
Balance exercises for persons ≥ 65 years. 
Maria Borland 
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Figure 1. Definition of exercise, physical activity and physical fitness. Adopted from 
Caspersen et al (4). 
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1.3 Cardiac Rehabilitation 
Cardiac rehabilitation (CR) is defined by the WHO as the “sum of activity 
and interventions required to ensure the best possible physical, mental, and 
social conditions so that patients with chronic or post-acute coronary artery 
disease (CAD) may regain their proper place in society and live an active 
life” (38). The multidisciplinary approaches in CR/secondary prevention 
programmes are based on reducing cardiac events and decreasing disease 
progression (39). An overview of the core components in CR is presented in 
Table 7.  
Table 7. Core components of cardiac rehabilitation/secondary prevention 
programmes. Adapted from Balady et al (40).  
Patient assessment Diabetes management 
Nutritional counselling Tobacco cessation 
Weight management Psychosocial management 
Blood pressure management Physical activity counselling 
Lipid management  Exercise training 
 
 Physiotherapy 
The tradition of physiotherapy in Sweden began in 1813, when Per Henrik 
Ling started the Royal Central Gymnastic Institute. Physiotherapy promotes 
health with the purpose of maintaining or improving inter alia physical 
fitness (41). Physiotherapy is the third largest health profession in Sweden 
and the Western world after physicians and nurses (41).  
According to the World Confederation for Physical Therapy (WCPT), 
physiotherapy is “services provided by physiotherapist to individuals and 
populations to develop, maintain, and restore maximum movement and 
functional ability throughout the life span” (42). The WCPT states that 
physiotherapy involves the interaction between the physiotherapist patient, 
and other health professionals in identifying and maximising the quality of 
life and movement potential within the spheres of promotion, prevention, 
treatment/intervention, habilitation, and rehabilitation. These spheres 
encompass physical, psychological, emotional, and social well-being (42). 
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 Physiotherapist-led group-based exercise within cardiac 
rehabilitation 
Exercise training is one of the core components of CR (40, 43), strongly 
influencing all-cause and cardiovascular mortality and reducing hospital 
admissions in patients with CAD and chronic HF (7, 44). One meta-analysis 
showed that CR increased the cardiorespiratory physical fitness by 1.5 METs 
that corresponds to a cardiac mortality reduction of 16-54% (45). The 
physiotherapist is an exercise expert in the multidisciplinary team and has the 
task of prescribing individual-based exercise after clinical examination and 
risk stratification of each patient, as well as leading the group-based exercise 
(39, 46).  
PT-X consists of continuous or interval aerobic exercise 3-5 days a week at 
60-85% of the highest achieved oxygen uptake (VO2 peak) during 20-60 
minute sessions, and muscular resistance exercises 2-3 days a week in 10-15 
repetitions of 1-3 sets of 8-10 different upper and lower body exercises (40). 
Exercise-based CR should be medically supervised and include a clinical 
physical examination with blood pressure control, HR, and heart rhythm 
assessment before, during, and after exercise training (46). PT-X also 
includes an evaluation of possible exercise-limited comorbidities, assessment 
of behavioural characteristics (i.e., experience of exercise and physical 
activity, readiness to change behaviour, self-confidence, barriers, and social 
support), and the patient’s personal goals and exercise preferences (46).  
 Physical activity on prescription 
PAP is one method used in health care to increase physical activity to reduce 
the risk of developing lifestyle-related diseases (11). This method is often 
used together with motivational interviewing, and all registered medical 
professions are allowed to prescribe PAP to patients with or without cardiac 
disease. PAP does not include any physiotherapist-led supervised exercise, 
and the patients are expected to exercise on their own. 
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1.4 Exercise Modalities within Physiotherapist-led 
Exercise within Cardiac Rehabilitation  
PT-X includes both aerobic exercise and muscular resistance exercises. In 
this thesis, patients with chronic HF and AF performed aerobic exercise on an 
ergometer cycle. The aerobic exercise consisted of aerobic continuous 
exercise (ACT) in study I, and aerobic interval exercise (AIT) in study II. The 
muscular resistance exercise was performed as peripheral muscular exercise 
in study I, and as circuit training focusing on muscle endurance 
improvements in study II.  
 Aerobic exercise 
Central circulatory aerobic exercise in PT-X includes ACT and/or AIT (1, 
47). ACT is a submaximal, sustained, steady state aerobic exercise. AIT 
alternates high intensity with moderate to low intensity exercise. In aerobic 
exercise, the intensity must exceed the required energy system for 
improvements in cardiorespiratory fitness (1, 47). Studies have shown 
conflicting results regarding the favour of one concept in improving physical 
fitness over the other (48, 49).  
 Muscular resistance and endurance exercise 
PT-X includes dynamic muscle work with a constant weight in the concentric 
and eccentric phase during each repetition (3). A resistance training 
programme includes exercise modalities with the aim of improving muscle 
cellular hypertrophy, strength, power, and endurance (3). The acute 
physiological responses and chronic adaptations to a resistance training 
programme depend on the choice and order of exercises, number of sets of an 
exercise, training intensity, and length of the rest periods between the sets 
and exercises (3). Exercises aiming to increase hypertrophy and muscle 
endurance are included in CR. The training programmes include concentric 
and eccentric muscle work in the lower and upper parts of the body at a given 
relative effort (50). 
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 Peripheral muscle training 
In peripheral muscle training, exercise is focused on working with a small 
muscle mass prescribed for use at the same time. This results in a high 
relative load on the individual muscle group with small cardiorespiratory 
stress (51). This training is suitable for patients with chronic HF and/or 
patients with low exercise capacity due to deconditioning or reduced CO (51-
53). 
1.5 Physiological Response to Physiotherapist-led 
Exercise within Cardiac Rehabilitation  
Exercise involves acute responses and chronic adaptations in both central and 
peripheral functions in both healthy individuals and patients with heart 
disease (54). An improvement in VO2peak is important because it strongly 
influences all cause and cardiovascular mortality in both healthy individuals 
and patients with cardiac disease (55, 56). Improvement in VO2peak also 
improves prognosis and AF-related symptoms and episodes in patients with 
non-permanent AF (57, 58). An overview of the differences and similarities 
in chronic adaptations from exercise between healthy individuals, patients 
with chronic HF, and patients with AF is presented in Table 8 (54, 59-61). 
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Table 8. Overview of chronic adaptations from exercise. Adapted from Lavie 
et al (54), Piepoli et al (59), Hirari et al (60) and Reed et al (61).  
HF: Heart failure, AF: Atrial fibrillation, LV: Left ventricular, EF: Ejection fraction, HR: Heart rate, SV: 
Stroke volume, CO: Cardiac output, O2 delivery: Oxygen delivery, VO2max: Maximal rate of oxygen 
consumption, VO2peak: Peak rate of oxygen consumption, a-v O2 diff: Arteriovenous oxygen difference. 
 
 Healthy Chronic HF AF 
Autonomic nervous system  
Sympathetic excitation  ↓  
Heart  
LV size ↑ ↓  
EF ↔ ↑  
SV at rest and during exercise ↑ ↑  
HR at rest  ↓ ↓ ↓ 
HR, submaximal exercise ↓ ↓↔ ↓ 
HR maximal ↔ ↑  
CO at rest and submaximal exercise  ↔ ↑  
Endothelium-mediated coronary dilation  ↑  
Skeletal muscle   
Muscle fibre type I ↑ ↑  
Mitochondria volume ↑ ↑  
Oxidative enzyme activity ↑ ↑  
O2 delivery ↑ ↑  
Vessels  
Vasoconstriction  ↓  
Total peripheral resistance ↓ ↓  
Systemic arterial compliance ↓ ↑  
Endothelium-mediated vasodilation ↓ ↑  
Circulating cytokines  ↓ ↓  
Metaboreflex (ergoreceptor)  ↓  
Blood  
Blood flow ↑ ↑  
Vascular resistance ↓ ↓  
Plasma volume ↑ ↑  
Capillaries per fibre ↑ ↑  
Metabolics  
VO2max ↑ ↑  
VO2peak ↑ ↑ ↑ 
 a-v O2 diff ↑ ↑  
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 Cardiovascular system and metabolics 
Cardiovascular function and the chronic effects of exercise are complex and 
multifactorial. In this thesis, the effects related to physical fitness are 
discussed. Other adaptations in the body are also important, but not focused 
on in this thesis. The chronic adaptations induced by aerobic exercise lead to 
an increased maximal oxygen uptake (VO2max) of 20% on average in both 
healthy individuals and patients with chronic HF (62, 63).  
Two major factors are important for both the improvement and limitation of 
VO2max. The CO and/or capacity for active muscle to extract oxygen from the 
arterial blood (i.e., the arterial venous oxygen difference (a-vO2diff)). The 
limiting factor for VO2max is the CO, and exercise can improve the CO in 
healthy individuals (64). The determinants of VO2max are given in Fick’s 
equation: VO2max = COmax × a-vO2diff max (1).  
However, in patients with chronic HF, the ability to improve VO2max through 
an increased CO is limited. Therefore, the most important factor to improve 
in these patients is the a-v O2diff (62).  
In patients with permanent AF, the chronic adaptations from aerobic exercise 
have been sparsely investigated. Studies have found a decreased HR at rest 
and submaximal exercise (61). One meta-analysis reported that exercise may 
have the potential to improve systolic function, especially in patients with AF 
and HFrEF (65). 
  Skeletal muscle adaptation  
In chronic HF, exercise induces alterations in the skeletal muscle, such as 
increased mitochondrial volume and density, oxidative enzyme activity, and 
increased capillary per muscle fibre ratio. Exercise also produces a shift to a 
larger proportion of oxidative muscle fibre type 1 with a greater muscle fibre 
area. The lactate threshold will increase and the O2 cost decrease (60). This 
leads to a decreased ventilator drive and enhanced muscle ergo reflex (59). 
In patients with permanent AF, the effect of aerobic exercise on the muscular 
system has not been investigated.  
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 Detraining 
Cessation of exercise causes detraining alterations in both the short term (< 4 
weeks) and longer term (> 4 weeks). Detraining was defined by Mujika et al 
(2) as “the partial or complete loss of training-induced anatomical, 
physiological, and performance adaptations as a consequence of training 
reduction or cessation”. According to Kramer et al (3), detraining is “a 
cessation (stopping) or reduction of training or a decrease in physical 
performance caused by a cessation or reduction in training”. In this thesis, the 
effects of 3 months detraining were studied in patients with permanent AF. 
The physiological effects of detraining in patients with permanent AF have not 
previously been studied. However, the effects of detraining in healthy athletes 
and recently trained individuals have been investigated (2, 66). The 
cardiorespiratory characteristics and muscular characteristics of long-term 
detraining in recently trained healthy individuals are presented in Table 9. 
Table 9. Overview of the effects of detraining in healthy, recently trained 
individuals. Adapted from Mujika et al (2, 66). 
Detraining characteristics  Recently trained healthy individuals 
Cardiovascular characteristics  
Blood volume ↓ 
HR submaximal ↑ 
SV during exercise ↓ 
CO max ↓ 
Blood pressure (MAP) ↑ 
Muscular characteristics  
Capillary density ↓ 
Oxidative enzyme activity ↓ 
Mean fibre cross sectional area ↓ 
Muscle mass ↓ 
Strength and power performance ↓ 
Metabolics  
A-VO2 diff Not investigated in recently trained. ↓ in athletes 
VO2max ↓ 
VO2peak ↓ 
HR: Heart rate, SV: Stroke volume, CO: Cardiac output, MAP: Mean arterial blood pressure, VO2max: 
Maximal rate of oxygen consumption, VO2peak: Peak rate of oxygen consumption,  a-v O2 diff: 
Arteriovenous oxygen difference. 
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 Cardiovascular system 
VO2max reverses to pre-training levels, but different degrees of retention have 
been reported. Detraining results in a higher HR at rest and submaximal 
exercise and, consequently, decreased CO (66). A decrease in red blood cell 
volume and plasma volume has been observed in young recently trained 
individuals (67), which can partially explain the decline in VO2max.  
 Skeletal muscle system 
In skeletal muscle, detraining causes a decline in muscular capillaries. 
Whether a decline in the a-v O2 diff occurs in recently trained individuals has 
not been investigated. However, a-v O2 diff is reversed in athletes, and 
mitochondrial adenosine triphosphate (ATP) production is reversed in 
recently trained individuals in the short term (< 4 week), so it can be assumed 
that this is also possible in the long term (2, 66).   
1.6 Health-related Quality of Life 
The term HR-QoL is not defined in the literature, and measures of health 
status often use the terms HR-QoL and quality of life interchangeably (68). 
The importance of measuring quality of life was highlighted in the 1960s 
when medical treatment was able to extend the length of life, sometimes at 
the expense of quality of life, and the measurement of death rates was not 
enough to measure the population’s health (68, 69). The term HR-QoL was 
developed from quality of life to include the individual’s health status, 
experience with disease, and process of natural aging. According to Karimi et 
al (68), HR-QoL overlaps the terms health and quality of life, and is often 
used as the individual self-perceived health status. According to the WHO, 
health is defined as “a state of complete physical, mental, and social well-
being, and not merely the absence of disease and infirmity”(70) . The WHO 
has defined quality of life as “the individual’s perception of their position of 
life in the context of their culture and value systems in which they live and in 
relation to their personal goals, expectations, standards, and concern” (71).  
Even though advanced medical techniques are available, patients with 
chronic HF have a severe symptom burden and high mortality rates as well as 
frequent hospital admissions. HR-QoL is worse in patients with chronic HF 
than in other chronic cardiac and non-cardiac diseases (72, 73). The main 
symptoms of chronic HF are breathlessness and fatigue; other symptoms are 
presented in Table 1, several of which greatly impact HR-QoL (74-76). 
Patients with chronic HF are often symptom-limited, have low physical 
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fitness and a limited ability to perform a wide range of daily physical 
activities and exercise (74, 75, 77). In patients with chronic HF, reduced HR-
QoL has been associated with a younger age and the severity of symptoms, 
which restrict physical activity and social functioning and cannot be 
normalised with optimal medical treatment (74).  
Similarly, patients with AF often experience symptom-related limitations, 
which affect HR-QoL. The severity of symptoms and type of AF are related 
to a greater negative impact on HR-QoL (73, 78, 79), despite advanced 
pharmacotherapy and electrotherapy treatments. The occurrence of 
arrhythmia, and the frequency and duration of the attack can be unpredictable 
and require emergency hospital admissions, which negatively influence the 
patients’ HR-QoL. Dorian et al (80) reported that 90% of patients with non-
permanent AF have symptoms during AF episodes. Symptoms of AF 
negatively affect the patient’s physical fitness, social life, professional life, 
and activities of daily living (33, 78, 81, 82), as well as HR-QoL, and 
increase the risk of depression in patients with all types of AF (82, 83).  
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 General exercise principles 
There are six exercise principles for the prescription and planning of exercise 
to optimise its effects (84).  
• Individuality: not all individuals respond the same way to 
exercise stimuli; therefore, it is important that the exercise 
programme meet the individual’s needs.  
• Specificity: physiological responses adjust to the exercise 
performed; to achieve improvements, the exercise must be 
adjusted to meet the desired demand.  
• Overload: the relationship between exercise intensity and desired 
effect; the exercise programme must include intensities greater 
than normal to progress to a higher work level. 
• Reversibility or disuse: reversibility of the effects of 
physiological exercise will occur if exercise is ceased (i.e., 
detraining).  
• Hard and easy: a period of hard exercise is followed by a period 
of easier exercise.  
• Periodisation: exercise is planned and divided into periods, 
enabling athletes to be at their best when needed. 
In PT-X, four principles are considered when conducting an 
exercise programme. The principles of hard/easy and 
periodisation are not commonly used in PT-X. The exercise 
programme is individually prescribed according to the patients’ 
medical status and include the mode, frequency, duration, 
intensity, and progression of exercise (85). 
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2 GAPS OF KNOWLEDGE WITHIN 
EXERCISE-BASED CARDIAC 
REHABILITATION REGARDING 
CHRONIC HEART FAILURE AND 
ATRIAL FIBRILLATION 
There are some gaps in the knowledge regarding PT-X in patients with 
chronic HF and AF. In this thesis, some of these gaps are studied, but not all. 
When I started my PhD project, PT-X had high evidence in patients with 
chronic HF, but not in patients with AF. As I have worked on this project, the 
knowledge has increased regarding the importance of lifestyle management 
for patients with AF (28). However, knowledge gaps still exist regarding PT-
X and its effect on mortality and hospital admissions in patients with AF 
(10), and if it should be included in the multidisciplinary management of 
patients with AF (8, 28).  
When I started my PhD project, ACT was the superior form of aerobic 
exercise within PT-X. Today, AIT with higher exercise intensities is more 
common and widely used within PT-X (47). However, which exercise 
regimen will benefit patients with chronic HF in the long term and patients 
with permanent AF in the short and long term remains unknown. 
During the years I have worked as a physiotherapist on PT-X, it has become 
more common that different medical professions recommend patients to 
increase their physical activity level. This is often achieved with an 
alternative to PT-X when patients are unable to participate for different 
reasons. There are still knowledge gaps regarding the amount of physical 
activity and dose response relationship of the physical activity needed to 
achieve improved physical fitness.  
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3 AIMS AND HYPOTHESIS OF THE 
THESIS 
3.1 General Aims 
The general aim of this thesis was to investigate the effect of individually 
prescribed PT-X in elderly patients with chronic HF or permanent AF, 
especially in regards to exercise modality, physical fitness, level of physical 
activity, HR-QoL, and metabolic risk factors.  
3.2 Specific Aims and Hypothesis  
Study I aim: To assess the impact of PT-X on the level of physical activity, 
physical fitness, and HR-QoL in patients with chronic HF and comorbidity, 
and to assess the correlations between baseline values for physical activity, 
physical fitness, sitting time, and HR-QoL.  
Primary outcome measure: steps per day.  
Hypothesis: PT-X will increase the physical activity level in patients with 
chronic HF.  
Study II aim: To assess and compare the impact of PT-X or PAP on physical 
fitness, the level of physical activity, HR-QoL, metabolic risk markers, and 
safety in patients with permanent AF.  
Primary outcome measure: exercise capacity in Watts.  
Hypothesis: PT-X will increase physical fitness significantly more than PAP 
in patients with permanent AF. 
Study III aim: To assess the impact of a 3-month detraining after PT-X or 
PAP regarding physical fitness, the level of physical activity, and HR-QoL in 
patients with permanent AF, and if any variable could predict the possible 
change in physical fitness.  
Hypothesis: Detraining will affect physical fitness in patients with permanent 
AF.  
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4 PATIENTS AND METHODS 
This thesis is based on the three studies described below, Table 10. The 
patients were recruited from both rural and urban hospitals and primary 
health care in Region Västra Götaland in Sweden. For studies I and II, the 
randomisation tickets were kept in sealed envelopes constructed by a person 
not working at the clinic.  
Table 10. Overview of studies I-III. 
Study                                                Patients 
I 48 patients (10 women), mean age 71 ± 8 years, EF 27 ± 10%, with 
chronic HF and comorbidities in NYHA functional class II-III. 
42 patients completed the study, 6 dropped out.  
II 96 patients (28 women), mean age 74 ± 5 years with permanent 
AF.  
87 patients completed the study, 9 dropped out. 
III 80 patients (22 women), mean age 74 ± 5 years with permanent 
AF.  
 
4.1 Study Design  
Studies I-III: Experimental randomised controlled trial.  
4.2 Selection of Participants, Inclusion and Exclusion 
Criteria 
Study I: Fifty-three patients were assessed for eligibility from Alingsås 
hospital and the primary healthcare in south-western Sweden between 2009 
and 2011. Forty-eight patients fulfilled the inclusion criteria, consented to 
participate, and were recruited for baseline testing. After baseline testing, the 
patients were randomised and included in the study. The inclusion criteria 
were stable chronic HF, NYHA functional class II-III. The exclusion criteria 
were difficulties participating in the test procedure or insufficient command 
of the Swedish language. The inclusion process and reasons for exclusion and 
drop-out are presented in Figure 2. 
 
Maria Borland 
23 
Figure 2. Flowchart over the inclusion process study I. 
 
 
 
 
 
 
 
 
 Assessed for eligibility (n=53)  
Excluded (n=5) 
Did not meet inclusion criteria (n=3) 
Declined to participate (n=2) Randomised (n=48) 
Randomised to intervention (n=25) 
Received allocated intervention (n=21) 
Randomised to control (=23) 
Did not complete control period (n=3) 
Lost to follow up at discharge (n=4)  
Died (n=1) 
Orthopedic surgery (n=1)  
Did not want to complete training period (n=1)                         
Medical causes (n=1) 
Available for analysis at discharge (n=22) 
Excluded from analyses (n=3) 
Died (n=1) 
Orthopedic surgery (n=1) 
Medical causes (n=1) 
 
Available for analysis at discharge (n=20) 
Excluded from analyses (n=3) 
Died (n=1) 
Coronary bypass surgery (n=1), 
Did not want to do retest after ICD 
implantation (n=1) 
Lost to follow up at discharge (n=3)  
Died (n=1) 
Coronary bypass surgery (n=1)  
Did not want to do retest after lCD 
implantation (n=1)  
 
Analysed (n=22) Analysed (n=20) 
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Study II: Five hundred and thirty-eight patients were assessed for eligibility 
to participate in a multi-centre study at Alingsås Hospital, Sahlgrenska 
University Hospital, and primary healthcare in south-western Sweden 
between 2014 and 2016. Patients were also recruited via advertisements in 
local papers. A total of 98 patients fulfilled the inclusion criteria, consented 
to participate, and were recruited for baseline testing. At baseline, one patient 
was excluded due to ventricular bigeminy. Therefore, 97 patients were 
randomised. One patient was excluded during the intervention because an 
ECG showed sinus rhythm, resulting in 96 patients being enrolled in the 
study. Inclusion criteria were permanent AF verified by ECG and LVEF ≥ 
45%. Exclusion criteria were significant valvular lesions, coronary event 
within 3 months prior to inclusion, stroke with residual symptoms, 
pacemaker, or not being able to participate in the test procedure or read 
Swedish. The inclusion process and reasons for exclusion and drop-out are 
presented in Figure 3. 
Study III: Eighty-seven patients completed study II and were assessed for 
eligibility in the 3-month follow-up. Out of these, 80 patients completed a 3-
month detraining period and were included in the study. The patients 
followed their earlier randomisation. The inclusion process and reasons for 
drop-out are presented in Figure 4.  
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Figure 3.  Flowchart over the inclusion process in study II. 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n=538) 
Excluded (n=420) 
♦   Not meeting inclusion criteria (n=396) 
♦   Not interested (n=24)  
Analysed (n=47) 
 
Lost to follow-up (n=3)                                                
Medical reasons (n=1)                                             
Lack of time (n=2)  
Allocated to intervention PAP (n=50) 
♦ Received allocated intervention (n=47) 
♦ Did not receive allocated intervention  (n=3)                  
Medical reasons (n=1 )                                    
Withdraw participation (n=2) 
Lost to follow-up (n=6)                                                          
Medical reasons (n=4)                                              
Lack of time and travelling (n=2) 
Allocated to intervention PT-X (n=47) 
♦ Received allocated intervention (n=40) 
♦ Did not receive allocated intervention  (n=7)    
Inaccurate randomized persistent AF (n=1)                                      
Medical reasons (n=4)                                                 
Withdraw participation (n=2) 
Analysed (n=40) 
 
Allocation 
Analysis 
Follow-Up 
Randomised (n=97) 
Enrollment 
Received written information (n=118) 
Assessed for eligibility for echocardiography (n=108)                         
♦   Available echocardiography (n=14)                                                 
♦   New echocardiography (n=94)                               
Excluded (n=10) 
♦   Not interested (n=10)  
 
Excluded after echocardiography (n=10) 
Not meeting inclusion criteria (n=10) 
Baseline testing (n=98) 
Excluded ventricular arrhythmia                                           
during ergometer test (n=1) 
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Figure 4.  Flowchart over the inclusion process in study III. 
 
 
 
 
 
 
 
 
Assessed for eligibility (n=87) 
Analysed (n=42) 
 
Lost to follow-up (n=5)                                                    
Medical reasons (n=2)                                                   
Withdraw participation (n=2)                                           
Died (n=1) 
Allocated to intervention PAP (n=47) 
♦ Received allocated intervention (n=42) 
♦ Did not receive allocated intervention (n=5)          
Medical reasons (n=2)                                    
Withdraw participation (n=2)                                  
Died (n=1) 
Lost to follow-up (n=2)                                              
Medical causes (n=1)                                              
Withdraw participation (n=1) 
Allocated to intervention PT-X (n=40) 
♦ Received allocated intervention (n=38) 
♦ Did not receive allocated intervention (n=2)               
Medical reasons (n=1)                                         
Withdraw participation (n=1) 
Analysed (n=38) 
 
Allocation 
Analysis 
Follow-Up 
Randomised (n=87) 
Enrollment 
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4.3 Data Collection 
The outcome measurements included in this thesis are presented below in 
detail and listed in Table 11. As much as possible, the measurements were 
collected by the same physiotherapist blinded to group assessment at the 
same hour of the day at baseline, after intervention, and at follow-up. 
Table 11. Overview of outcome measurements. 
Measurements  Study I Study II Study III 
BMI [kg/m2]  x x 
TTE  x  
Blood samples  
Plasma glucose  x  
Cholesterol mmol/L  x  
HDL mmol/L  x  
LDL mmol/L  x  
Triglycerides mmol/L  x  
HbA1C mmol/mol  x  
Physical fitness test  
Symptom-limited ergometercycle test x x x 
6MWT  x   
Unilateral isoinertial shoulder flexion x x x 
Bilateral isometric shoulder abduction x x x 
Unilateral isoinertial heel-lift x x x 
RPE  x x x 
CR10  x x x 
Physical activity   
Keep walking pedometer  x   
Actigraph accelerometer GT3x  x x 
IPAQ x x x 
Saltin-Grimby Physical Activity level 
6 grade scale 
  x 
Health-related quality of life   
Short form SF-36  x x x 
BMI: Body mass index, TTE: Trans-thoracic echocardiography, HDL: High density 
lipoprotein, LDL: Low density lipoprotein, HbA1C: Glycated haemoglobin A1c, Borg RPE: 
Rating of perceived exertion, Borg scale 6-20, 6MWT: Six-minute walk test, Borg CR10: Borg 
category ratio scale for rating of dyspnoea and pain, IPAQ: International Physical Activity 
Questionnaire, SF-36: Short form health survey SF-36 
 
 
Exercise-based cardiac rehabilitation, physical fitness, and physical activity 
in cardiac disease. 
28 
 Measurements 
Body mass index (BMI) (studies II, III): Body weight and height were 
assessed upon clinical examination and BMI calculated as the weight in 
kilograms divided by the height in meters squared [kg/m2] (1).  
Age and gender (studies I, II, III) were used to describe the study population 
in all studies and for stratification.  
Trans-thoracic echocardiography (study II): LV-EF, LV volume, and 
valvular function were evaluated by both visual estimates and using the 
apical two- and four-chamber view according to the biplane method of disks 
(Simpson’s rule) to determine the end-diastolic volume and end-systolic 
volume. Two-dimensional Doppler echocardiography (Vidid 7 and Vivid E9, 
General Electric Medical systems, Horten, Norway) was performed using a 
phased-array transducer (1.5-4.0 MHz). Images were obtained from the 
parasternal long axis and apical four- and two-chamber views. Pulsed and 
continuous Doppler flow velocities across the mitral valve and left 
ventricular outflow tract were acquired according to the American Society of 
Echocardiography (86). Offline analysis was performed using commercially 
available Echopac PC software (General Electric Ultrasound, Horten, 
Norway). 
Venous blood sampling for cardiac risk markers (study II): Plasma 
glucose, glycated haemoglobin A1c (HbA1c), total cholesterol, high density 
lipoprotein (HDL), low density lipoprotein (LDL), and triglycerides were 
measured. Blood was collected after an overnight fast and analysed according 
to the European accreditation system (87). The blood test results were 
received only as a laboratory report on paper, and no blood samples were 
reposted for later use. 
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 Physical fitness  
Exercise capacity (studies I, II, III) was measured by a symptom-limited 
ergometer cycle test based on the WHO protocol (88) performed on a 
Monark ergometer 839e (Monark, Varberg, Sweden). The workload began at 
25 W and was increased by 25 W every 4.5 min. The Borg scale (RPE 6-20) 
was used to assess the rate of exertion (89). HR was recorded every 2nd 
minute, and blood pressure was measured manually using a sphygmometer 
and stethoscope on the right arm every 3rd minute during each interval. If the 
patient did not sustain the final step, the maximal power was adjusted 
according to Strandell’s formula: maximal power = (submaximal power) + 
(25×n/4.5) (90, 91). Thus, in this thesis, maximal power = (maximal Watts 
achieved - 25 W) + (25×time in max Watts/4.5).  
In study I, the workload increased until the patient rated 15-17 on the RPE 
scale. In studies II and III, the workload increased until the patient rated RPE 
17. Symptoms, such as dyspnoea and pain, were assessed with the Borg 
category ratio scale (CR-10) (89).  
The instructions to the patient before testing were to avoid nicotine, coffee, 
tea, or any drinks containing caffeine at least 2 hours before examination. 
Furthermore, the patients were requested to not perform strenuous physical 
activity the day before testing.  
Exercise capacity related to activities of daily living (study I) was 
measured by a standardised 6-minute walking test (6MWT). The instructions 
were to walk on a pre-marked 30-m corridor for 6 min, covering as much 
distance as possible. No encouragement or coaching was provided during the 
test. Distance walked and HR were measured using a sport-tester pulse watch 
(Polar Electro OY, Kempele, Finland). For rating of perceived exertion and 
dyspnoea, the RPE scale and Borg CR-10 scale (89) were recorded. The test 
has an inverse relationship with NYHA classification and strongly correlates 
with VO2peak, which is a prognostic marker in patients with HF (92). The 
6MWT has good validity and reliability for patients with chronic HF (92, 93).  
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Muscular endurance (studies I, II, and III) was measured with three clinic-
based tests. These tests have been proven to be reliable for measuring muscle 
endurance in patients with chronic HF and CAD (94, 95). 
Unilateral isoinertial shoulder flexion: The patient sat on a stool with their 
back touching the wall, holding a 2 kg (women) or 3 kg (men) dumbbell in 
their hand. Twenty shoulder flexions/minute were performed at a pace of 40 
beats per minute (bpm) set by a metronome (Taktell, Wittner, Germany 
(study I) or Seiko instruments, Chiba, Japan (studies II and III)). The patient 
was told to do as many repetitions as possible.  
Bilateral isometric shoulder abduction: The patient held a 1 kg dumbbell 
in each hand using the same body position as in shoulder flexion. The patient 
was asked to elevate both arms to 90° of shoulder abduction and maintain this 
position as long as possible. After being reminded once when losing the 
position, the test was ended and the time recorded.   
Unilateral isoinertial heel lift: Touching the wall for balance, with shoes on, 
the patients performed a maximal unilateral heel lift as high as possible with 
a straight knee on a 10° tilted wedge. Thirty heel lifts/minute were performed 
and the metronome kept a 60 bpm pace.  
 Physical activity 
Physical activity level was measured both objectively and subjectively. 
Pedometer (study I): Steps per day were measured by a Keepwalking 
LS2000 pedometer (KeepWalking Scandinavia, Kalmar, Sweden). The 
pedometer was placed on the patient´s hip and worn for 7 days except when 
showering or bathing. Overweight patients were instructed to place the 
pedometer on their ankles. Patients were instructed to record the total number 
of steps on a log sheet at bedtime and reset the device to zero each morning 
(96). A pedometer counts the uniaxial vertical movement of the hip (97). The 
validity and reliability of this pedometer has been shown to be satisfactory in 
adult populations (98). 
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Accelerometer (studies II and III): Daily physical activity was measured by 
an accelerometer (Actigraph® GT3x+, Actigraph, Pensacola, Florida, USA) 
placed on the patient´s hip and worn throughout the whole day for 7 days 
except when showering or bathing (97). Actigraph GT3x is a tri-axial 
accelerometer detecting acceleration (difference in velocity/time, m/s2) in 
three axes (vertical, medio-lateral, and anterial-posterial). The accelerations 
were collected as activity counts, with accelerations due to body movement at 
different intensities to predict energy expenditure (99, 100). The amount of 
physical activity and sedentary time were determined by classifying activity 
counts accumulated over a specific length of time (epoch length) (100). The 
accelerometer data were analysed according to the algorithm created by Choi 
et al (99). These monitors are reliable and valid in the adult population (97, 
101-104). 
Self-reported physical activity (studies I, II, and III) was measured by the 
Swedish version of the IPAQ (105). The IPAQ was developed to compare 
measurements of self-reported physical activity across countries in 
epidemiological studies. In the questionnaire, three types of physical activity 
are requested (walking, moderate-intensity activities, and vigorous physical 
activities) in four domains: leisure-time physical activity, domestic and 
gardening (yard) activities, work-related physical activity, and transport-
related physical activity. The intensity of physical activity is classified as 3 
(high level, 1 hour of at least moderate physical activity above the basal level 
of physical activity or half an hour of vigorous physical activity, e.g., 12 500 
steps/day or the equivalent in moderate or intense physical activity) 2 
(moderate level, defined as performing some activities more often than in the 
lowest category or the equivalent of half an hour of at least moderately 
intense physical activity on most days), or 1 (low level of physical activity, 
defined as not meeting the criteria for either of the previous categories). 
Metabolic expenditure is measured by equivalent METs per day 
(MET×minutes×day) and per week (MET×minutes×week) by weighting the 
reported minutes per week by the total expenditure (METs) estimate assigned 
to each category of activity. The total Kcal per week is calculated by the 
reported minutes per week and the person’s weight. The instrument also 
includes a question regarding time sitting (105). The IPAQ has been found to 
be valid and reliable, and measures physical activity over a 7-day period in 
METs, including sitting time (105). 
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Self-reported physical activity level during detraining (study III): To 
assess physical activity during detraining, Saltin-Grimby´s 6-grade physical 
activity scale was used (106). The scale is divided into six categories ranging 
from 1 (hardly any physical activity) to 6 (hard to very hard exercise). 
Household activities are also included in the scale. The scale has good 
reliability and validity in older populations and has been used in several 
studies including elderly patients with different medical conditions (107). 
The patients were instructed to rate the category that corresponded to their 
physical activity level during the 3-month detraining period.  
 Health-related quality of life 
Health-related quality of life (studies I, II, and III): To measure general HR-
QoL, the short form Health Survey Questionnaire (SF-36) (108) was used. 
This questionnaire has been used in several studies of chronic HF and AF 
(109). SF-36 contains 36 questions in eight dimensions rated from 0 (lowest 
health status) to 100 points (highest health status). The points summarise to 
two summary scores, each with a maximum 50 points. The eight dimensions 
are physical functioning (PF), role-physical (RP), bodily pain (BP), general 
health (GH), social functioning (SF), role-emotional (RE), vitality (VT), and 
mental health (MH). The two summary scores representing the overall index 
for physical and mental health are: the physical component summa score 
(PCS) comprising PF, RP, BP, and GH, and the mental component summa 
score (MCS) comprising SF, RE, VT, and MH (110). SF-36 has good validity 
and reliability, and there are reference values for the Swedish general 
population (111). 
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4.4 Interventions  
PT-X was designed based on the results of the ergometer test and the 
patient’s individual requirements and comorbidities using the RPE scale and 
CR-10 scale (89) to obtain the correct relative intensity of the exercise 
programme. The exercise programme included aerobic exercise and muscular 
endurance exercise in studies I and II. Study II included individually 
prescribed PAP. Exercise and PAP were prescribed according to guidelines. 
No exercise programme was conducted in study III, as the patients were 
instructed to avoid participation in any structured and organised exercise.  
 Exercise programme in study I 
PT-X consisted of two 60-minute sessions per week for 3 months of central 
circulatory exercise, peripheral muscular, and balance exercises. The control 
group was instructed to continue with their usual life during the 3-month 
study period, and thereafter were invited to participate in the exercise 
programme. The exercise programme is described in detail in Table 12. 
 Exercise programme in study II 
PT-X included central circulatory interval exercise and circuit exercise, two 
sessions per week, for 60 minutes, and two home-based exercise sessions. 
PAP included active walking, four sessions a week, for 40 minutes. The 
patients kept a diary for the home-based exercise and PAP. The exercise 
programmes for PT-X and prescription of PAP are described in detail in 
Table 13.  
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Table 12. Exercise programme in study I. 
Exercises Duration Repetitions RPE Set 
Aerobic exercise 15 min 1 12-13  
Resistance exercises     
Seated row in cable 
pulley  10-12 12-13 2 
Leg extension  10-12 12-13 2 
Heel lift on wedge  10-12 12-13 2 
Elbow flexion with 
dumbbell  10-12 12-13 2 
Elbow extension with 
dumbbell  10-12 12-13 2 
Bench press  10-12 12-13 2 
Balance exercise with 
and without eyes 
closed     
Standing with feet close 
together  2   
One leg standing  2   
Standing on different 
surface  2   
RPE: Rating of perceived exertion, Borg scale 6-20. 
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Table 13. Exercise programme in the PT-X group and active walking in the 
PAP group in study II. 
Interval exercise on 
ergometer cycle, PT-X 
Duration, min Repetitions RPE 
Warm-up period 6 1 11 
Interval I 2 4 15-17 
Interval II 2 4 13 
Cooldown period 2 1 11 
Resistance exercises,    
PT-X 
Duration, s 
exercise/rest/change 
Repetitions RPE 
Straight arm pull down in 
cable pulley 
45/15/30 2 13-15 
Leg extension  45/15/30 2 13-15 
Heel lift on wedge 45/15/30 2 13-15 
Step-up 45/15/30 2 13-15 
Shoulder flexion with 
dumbbell 
45/15/30 2 13-15 
Shoulder abduction with 
dumbbell 
45/15/30 2 13-15 
Bench press 45/15/30 2 13-15 
Squats with exercise ball 
against the wall  
45/15/30 2 13-15 
Wide grip push down in 
cable pulley  
45/15/30 2 13-15 
Home exercise    
programme, PT-X  
Duration, s 
exercise/rest/change 
Repetitions RPE 
Warm-up period with step-
up 
120  13-15 
 
Step-up, between exercises 120  13-15 
Elbow flexion, M. biceps 45/15/30 2 13-15 
Straight arm shoulder 
flexion  
45/15/30 2 13-15 
Shoulder abduction 45/15/30 2 13-15 
Standing row 45/15/30 2 13-15 
Heel lift 45/15/30 2 13-15 
Sit up 45/15/30 2 13-15 
Active walking PAP Duration, min Repetitions RPE 
Warm-up period 5 1 11 
Active walking 30 1 13-15 
Cool down period 5 1 11 
RPE: Rating of perceived exertion, Borg scale 6-20. 
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4.5 Statistics 
An overview of the statistical tests used in all studies is presented in Table 
14. The level of significance was p < 0.05 in all three studies. Analyses were 
performed in study I according to the protocol analysis. In studies II and III, a 
partial intention-to-treat (ITT) analysis was performed. For sensitive analysis 
in study II, a full ITT analysis was performed with baseline values carried 
forward, showing no effect on the results from the partial analysis. SPSS 
Windows version 19.0 and 22.0 was used for statistical analyses.  
Table 14. Overview of the statistical methods. 
Statistical test Study I Study II Study III 
Descriptive statistics x x x 
Chi squared (x2) x x x 
Yates correlation  x   
Wilcoxon signed rank test x x  
Mann-Whitney U-test x x x 
Spearman’s bivariate correlation 
coefficient test 
x  x 
Cohen’s d  x x 
Mixed effect model   x 
 
 Statistical power 
In studies I and II, the statistical power was calculated using a power (β) of 
80% and a significance level of (α) 5%. 
In studies I and II, an independent person not participating in the projects 
calculated and created the randomisation plots. The calculations were 
performed by a computer-based randomiser in Microsoft Excel as high and 
low plots. The patients received one or two points depending on age, gender, 
and 6MWT or exercise capacity. This was done in order to avoid the 
possibility of a homogeneous sample size.  
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In study I, the statistical power was calculated based on an assumption of a 
10% improvement in steps per day in the PT-X group and 4% in the control 
group; therefore, at least 48 patients (24 patients in each group) were needed.  
The patients were randomised to the PT-X or control group in a 1:1 ratio 
stratified for gender, age, and distance walked in the 6MWT.   
In study II, the statistical power was calculated based on an assumption of a 
difference of 10 ± 15 W in the improvement in exercise capacity in the PT-X 
group vs. the PAP group; therefore, at least 82 patients were needed, 41 
patients in each group. A dropout rate of 8% was estimated and we aimed to 
enrol ≥ 90 participants. The patients were randomised to PT-X or PAP in a 
1:1 ratio stratified for gender, age, and exercise capacity.  
 Descriptive data 
Descriptive statistics were used to present group characteristics. Ratio and 
interval data are presented as mean ± 1 standard deviation (SD), ordinal data 
are presented as median minimum and maximum values, and nominal data 
are presented in absolute and relative numbers.  
 Comparison between groups 
The X2 test and Mann-Whitney U-test were used to analyse differences 
between groups. To analyse comorbidities, pharmacotherapy, and pacemaker 
data in study I, Yates correlation was used. 
 Correlation  
Spearman’s bivariate correlation coefficient was used for correlations 
concerning physical activity and physical fitness and HR-QoL at baseline. 
The correlation was interpreted according to Munro (112): 0.00-0.25 as little 
if any correlation, 0.26-0.49 as low correlation, 0.50-0.69 as moderate 
correlation, 0.70-0.89 as high correlation, and 0.90-1.00 as very high 
correlation. 
 Effect size 
Cohen’s d was used to calculate the effect size using the mean difference 
between groups and pooled SD of the mean differences of both groups. The 
effect size was considered small for d = 0.2 – 0.3, medium for d = 0.5, and 
large for d = 0.8 (113). 
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 Predictors of change in physical fitness 
A mixed effect model was used to determine predictors of change in physical 
fitness. The independent variables were checked pairwise for possible 
collinearity, using Spearman r ≥ 0.7. In addition, for variable pairs with one 
categorical variable with few categories, we checked that boxplots 
overlapped. If both variables were categorical with few categories, we 
checked cross tables for > 80% observations in diagonal and cells with < 5 
observations. Three models were created, and each variable was checked 
stepwise and carried forward if p<0.20: model 1, intervention × time; model 
2, model 1 variable with addition of possible confounders (age, sex, and 
BMI); model 3, included secondary explanatory variables for physical fitness 
at baseline, mean value for heel lift left and right leg, SF -36 PF, IPAQ 
category, and moderate to vigorous physical activity measured by an 
accelerometer. The final model 3 consisted of model 1 variable, significant 
model 2 variables (age and sex), and significant secondary explanatory 
variables (SF-36 PF and moderate-vigorous physical activity measured by 
accelerometer). Variables in models were considered significant if p<0.05. 
4.6 Ethical Considerations 
The investigations conformed to the declaration of Helsinki and were 
approved by the Regional Ethics Committee of Gothenburg (study I, DNR 
808-8; study II, DNR 074-13, T-652-13, ClinicalTrials.gov NCT02493387; 
and study III, DNR 074-13, ClinicalTrials.gov NCT02493400). All patients 
received written and verbal information about the studies and provided 
written informed consent. All patients were informed that they could 
withdraw their participation without a given cause. The withdrawal did not 
impact further treatment of their health and diseases. Whether it is ethically 
correct to allow patients to participate in detraining when the evidence for 
improved physical fitness is high as previously discussed can be debated. 
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5 RESULTS 
The results of the studies included in this thesis are presented in the 
manuscripts attached to the printed version. Studies II and III are yet to be 
published. 
5.1 Study I 
A group-based exercise programme did not improve physical activity in 
patients with chronic heart failure and comorbidity: a randomised 
controlled trial.  
Forty-two patients completed the study; 6 patients dropped out (PT-X = 3, 
control = 3). PT-X was well tolerated and no adverse events occurred during 
the intervention. The physical activity level assessed as steps/day did not 
increase significantly after intervention (p=0.351), though the patients rated 
themselves as more physically active on the IPAQ (p=0.008). Physical fitness 
increased in exercise capacity on the ergometer cycle (p=0.001), walking 
distance on the 6MWT (p=0.014), and muscular endurance in shoulder 
abduction (p=0.028) and heel lift (p<0.0001). HR-QoL (p=0.018) also 
improved significantly in the PT-X group compared to controls. 
5.2 Study II 
Physiotherapist-led exercise-based cardiac rehabilitation versus physical 
activity on prescription for patients with permanent atrial fibrillation - a 
randomised controlled study focusing on physical fitness and physical 
activity. 
Eighty-seven patients completed the study; 9 patients dropped out (PT-X = 6, 
PAP = 3). No serious adverse events occurred during the study period in any 
group. Physical fitness improved significantly more after PT-X vs. PAP 
based on the exercise capacity on an ergometer cycle (p<0.0001) and muscle 
endurance in shoulder flexion left arm (p<0.001), shoulder abduction 
(p=0.010), and heel lift right leg (p<0.05) and left leg (p<0.001). The PAP 
group spent significantly more kilocalories and time in moderate and 
moderate to vigorous physical activity but did not have improved physical 
fitness. HR-QoL and lab tests did not significantly differ between the two 
groups. 
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5.3  Study III 
Physiotherapist-led exercise within cardiac rehabilitation-induced 
improvement in physical fitness is “perishable goods” in patients with 
permanent atrial fibrillation. 
Eighty of the 87 patients completing the intervention study (92%) 
participated (22 women; age 74 (±5) years). Physical fitness decreased 
significantly in the PT-X group (n=38) compared to the PAP group (n=42) in 
regards to exercise capacity on an ergometer cycle (p<0.0001) and muscle 
endurance in shoulder flexion (p<0.001). HR-QoL (SF-36 and RE function) 
was markedly reduced after detraining (p<0.010).  
The mixed effect model showed physical fitness changes over time, and that 
this change is different depending on the intervention. The pattern of change 
showed that the improved physical fitness achieved by PT-X was reversed 
after detraining, but was not equal to baseline values. The physical fitness in 
the PAP group remained relatively unchanged over time. This was confirmed 
after adjusting for confounders (age and sex) and the secondary explanatory 
variables SF- 36 PF and moderate to vigorous physical activity measured by 
an accelerometer. 
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6 DISCUSSION 
6.1 Discussion of Methods and Results 
The results of the studies included in this thesis clearly confirm that PT-X 
improves physical fitness in patients with chronic HF and comorbidities. In 
patients with permanent AF, PT-X is safe and improves physical fitness, 
whereas an individually prescribed PAP does not. The results also show that 
PT-X does not improve the physical activity level in patients with chronic HF 
and permanent AF, though the patients with chronic HF rated themselves as 
more physically active. Furthermore, cessation of PT-X can reverse the 
benefits achieved by PT-X in regards to physical fitness in patients with 
permanent AF.  
In study I, the patients were recruited from Alingsås Hospital and primary 
health care. In study II, the patients were recruited from Alingsås Hospital 
and Sahlgrenska University Hospital, primary health care, and from 
advertising in different local newspapers. These patients followed earlier 
randomisation in study III. Recruiting a mixed population from a small 
hospital outside Gothenburg, a university hospital, and primary health care 
makes it possible to generalise the results in a broader population compared 
to a narrower selection of patients from one hospital (114). The possibility of 
reaching the required number of patients more rapidly with a multicentre 
study also improves the external validity (114).  
 Intention-to-treat and per protocol analysis 
Missing participant data in RCT trials is commonly occurring (115). It is rare 
that every patient enrolled in a clinical trial follows the study protocol and 
complete all the allocated treatments and assessments. In the studies included 
in this thesis, the exercise duration consisted of 3 months PT-X or PAP. The 
adherence was good but some patients cancelled some of their exercise 
sessions, and a few withdrew their participation. In RCT studies, the ITT 
analysis is the gold standard method to analyse data (116). The ITT principle 
states that the analysis should include all study participants in the group to 
which they were originally allocated (116). This means that every patient 
who has entered the study is included in the final data analysis according to 
the treatment they were intended to have (112, 116).  
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ITT helps to preserve the benefits of a randomisation, which is intended to 
ensure that all the benefits in the outcome is solely an effect of the treatment 
(116) . However, when analysing the results, the missing participant data 
must be taken into account. There are different ways that data can be 
interpreted, the most commonly used is a single imputation as the last 
observation carried forward, but also mixed models for repeated measures 
and/or multiple imputations are used (117). In study I, we decided to analyse 
the data as per protocol (117). In study II, we analysed the results as a partial 
ITT including all available outcome measures howsoever adherence to the 
study protocol (117). For sensitive analysis in study II a full ITT analysis 
with last observation carried forward was performed, which did not alter the 
result compared to the partial ITT. Therefore, we decided to present the 
results from the partial ITT. It can be debated whether the result from the full 
ITT and not the partial ITT should be presented. However, we thought that by 
presenting the results from the partial ITT analysis, the real impact of the 
treatment for those who completed the study is shown.   
 Physical fitness 
The importance of high physical fitness regarding longevity and prognosis is 
well known in healthy individuals, as well as in patients with chronic HF and 
non-permanent AF (56, 57, 118, 119). A low VO2peak, exercise duration, and 
percentage of predicted VO2peak predicts the likelihood of premature death 
and a higher rate of hospital admissions in patients with chronic HF (118, 
120). Low VO2peak correlates with a high risk of mortality and/or stroke in 
patients with non-permanent AF (119). In study I, the patients with chronic 
HF and comorbidities had a low exercise capacity at baseline, corresponding 
to a poor prognosis; this was also indicated by the 6MWT and the results 
from the pedometer (92, 121). In study II, the patients with permanent AF 
had lower physical fitness than a healthy reference population (122).  
There are major health benefits to improving physical fitness with PT-X. In 
patients with chronic HF and all types of AF, exercise-based CR increases 
VO2peak (7, 10), and the health benefits of increased physical fitness have been 
confirmed by several studies (7, 55, 57, 58). Exercise-based CR reduces the 
mortality risk and hospital admissions in patients with chronic HF (7). Pathak 
et al (57) showed that an improvement in exercise capacity of ≥ 2 METs is an 
independent factor for arrhythmia freedom without drugs controlling 
arrhythmia and/or ablation when adjusted for weight loss in obese patients 
with non-permanent AF.  
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Increased VO2peak is also associated with reduced symptom burden in patients 
with non-permanent AF (57, 58). In patients with coronary heart disease, an 
increase in VO2peak is associated with an approximately 15% reduction in the 
risk of mortality (55). However, the evidence for mortality and serious 
adverse events in PT-X is still lacking for patients with AF (10). 
In study I, the patients improved their exercise capacity 15 W on average. In 
study II, the patients with permanent AF increased their exercise capacity an 
average of 16 W. Participating in PT-X also improved muscle endurance in 
patients with chronic HF and permanent AF. It is important for elderly 
patients to postpone a reduction in muscle function, as it improves activities 
of daily living and reduces the risk of falls (50).   
To assess exercise capacity and determine the intensity of exercise and 
physical activity in the studies included in this thesis, we used a symptom-
limited ergometer cycle test with a steady state protocol instead of a maximal 
cardiopulmonary ergospirometry test (CPX) with a ramp protocol. The 
symptom-limited ergometer cycle test is less expensive than a CPX, but the 
CPX is the gold standard of exercise tests (123). The symptom-limited test 
was based on the clinical aspect, and this is the standard test used at 
physiotherapy clinics in Sweden and performed without a physician present. 
A symptom-limited steady state test can also be more appropriate than a 
maximal ramp test in order to prescribe exercise (91).  
 Physical activity  
A low physical activity level in healthy people leads to reduced physical 
fitness and is associated with an increased risk of premature morbidity and 
mortality in several diseases (12). To increase their physical activity level, the 
patient can receive an individually prescribed PAP according to the 
guidelines given in Physical activity in the prevention and treatment of 
disease (FYSS) (11). In study II, PT-X was compared to PAP (11). The 
patients received an individually prescribed PAP consisting of active 
walking, which is the most common PAP prescription given by the medical 
profession (124, 125). PAP is most often prescribed without knowledge of 
the patients’ physical fitness or how to prescribe individual-based exercise.  
Active walking was used for comparisons to PT-X because we wanted to 
come as close to the clinical reality for the patients as possible. Whether 
active walking is the optimum way to prescribe PAP can be debated, as the 
recommendations in FYSS include aerobic central circulatory exercise and 
muscular resistance and endurance exercise, even though it is called physical 
activity (11).  
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Walking is considered a safe, daily, and feasible activity that can be 
performed easily by patients. However, a “brisk” walk can be of too 
strenuous intensity and unattainable for patients with very low physical 
fitness (< 3 METs) (126) and too low to improve physical fitness in patients 
with high physical fitness.  
Although the patients with permanent AF in the PAP group in study II 
increased the intensity of their physical activity, it was not enough to increase 
physical fitness. The patients in the PAP group spent more time in moderate 
and moderate to vigorous physical activity and achieved a higher energy 
expenditure as assessed by an accelerometer with no effect on physical 
fitness. The prescription of PAP included an individual visit with a 
physiotherapist and a 6-week follow-up return visit by the same 
physiotherapist. Leijon et al (127) has shown that adherence to PAP is low in 
the least active individuals due to multiple factors. It is recommended that 
PAP should be accompanied by motivational support, adjustment of the 
intervention, and evaluation (11, 128). At this visit, the ability to perform 
active walking was discussed, as well as the intensity, hinders, and barriers to 
performing the PAP. Conflicting results regarding the effect of PAP are 
found in the literature. Positive effects of PAP have been reported for 
metabolic risk factors, HR-QoL, and self-reported physical activity (129, 
130), whereas others have found no effect with respect to VO2max (130).  
Neither patients with chronic HF nor patients with permanent AF increased 
their physical activity level as assessed by steps per day or total step counts 
after participating in PT-X. Two meta-analyses reported conflicting results 
regarding whether exercise-based CR leads to a more active lifestyle. When 
comparing CR programmes, including centre-based exercise or home-based 
exercise, for patients after acute coronary syndrome, centre-based CR was 
not sufficient to increase and maintain the physical activity level. However, 
the result was more promising for home-based exercise CR (131). It may be 
easier to incorporate physical activity in daily life with home-based exercise 
programmes. None of the CR programmes improved physical activity levels 
in the longer term (≥ 6 months after completion) (131). On the other hand, 
Dibben et al (132) found moderate evidence that exercise-based CR 
improved physical activity levels. In this meta-analysis, patients with 
coronary heart disease and patients with HF were included, and the patients 
with HF were less likely to improve their physical activity level (132).  
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Dibben et al (132) discussed whether the mean improvement of 1423 
steps/day found in their meta-analysis is clinically meaningful and whether 
CR leads to an improvement in physical activity according to the guidelines 
of 150 minutes/week of moderate intensity physical activity. People living 
with chronic diseases are known to be less physically active (126). One study 
investigating whether patients with HF meet the recommended levels of 
physical activity found that no one managed to achieve the recommended 
levels of physical activity as measured by accelerometer data (133). 
According to accelerometer data, the patients were primarily engaged in light 
activities, but even this activity level was low (133). Patients with AF were 
not included in these studies. However, the recommended levels of physical 
activity in the WHO guidelines do not include patients with chronic HF and 
AF. The question remains, if patients with cardiac disease should focus on 
improving physical activity level or physical fitness.  
The lack of improvement in physical fitness with PAP can be due to the 
recommended levels for physical activity are insufficient to improve physical 
fitness. Elliot et al (134) stated that the recommended levels of physical 
activity are insufficient for health benefits in patients with non-permanent 
AF. They discuss whether a higher volume of exercise (equivalent to 210 
minutes/week) with the inclusion of vigorous exercise (≥ 6 METs) could be 
more appropriate. This supports the intensity of the physical activity being 
the most important factor for cardiorespiratory physical fitness and not the 
physical activity per se (56). 
In study I, the pedometer was used as an objective measure of physical 
activity based on the economic frame of the study. Pedometers have well-
known difficulties capturing slow walk and fast physical activity, such as 
jogging (97). There are also considerations in how to attach the pedometer in 
patients who are overweight or obese (97). In studies II and III, the 
pedometer was exchanged for an accelerometer for the objective 
measurement of physical activity. The accelerometer was worn in the same 
way as the pedometer, as there is less of a problem with attachment with a 
triaxial accelerometer in which the output is expressed as vector magnitude 
(97). The accelerometer has been proven to be more valid than the pedometer 
(97, 103). 
When measuring physical activity with a pedometer or accelerometer, we 
must take into account that we are not able to measure non-ambulatory 
physical activity, such as cycling and swimming. In all studies, the patients 
were told to take the device off when taking a bath, shower, or swimming, 
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but there was no restriction for cycling. It is possible to convert non-
ambulatory physical activity to METs (34, 135), but this was not done in 
these studies because our main interest was steps per day and no other forms 
of physical activity. If we had converted different kinds of physical activity, 
we may have obtained another result.  
In all studies, the objective measurement of physical activity was compared 
to the patient’s subjective rating of their physical activity level. For this 
purpose, the IPAQ was used (105). This questionnaire is considered a weak 
indicator of physical activity (136) but, together with an objective 
measurement, can be used to describe an individual’s physical activity level 
over 7 days. The difficulties with measuring self-reported physical activity 
are well known; Dyrstad et al (137) found that patients over-report physical 
activity compared to accelerometer data, especially at higher intensity levels. 
The results from study I concluded that the patients rated themselves as more 
physically active. This is congruent with Yates et al (133), as 38% of the 
patients rated themselves as physically active according to guidelines, though 
this was not confirmed by the accelerometer data. The reason for this 
discrepancy may be related to the increment in physical fitness, which may 
have improved the ability to perform physical activity with less effort and 
symptoms of breathlessness and fatigue. This may not increase the steps 
measured by the pedometer, which was our primary outcome measure; for 
example, performing household activities with less effort does not necessarily 
include more steps.  
 Health-related quality of life 
Exercise-based CR clearly improves HR-QoL in patients with chronic HF 
(7). In this thesis, patients with chronic HF and comorbidities had improved 
SF-36 PCS scores. A high prevalence of symptoms and symptom burden are 
associated with low HR-QoL in patients with chronic HF (74-76). In 
addition, VO2peak is associated with physical function in the elderly 
population (138). In study I, the patients had improved physical fitness and 
self-reported physical activity despite no increase in steps per day. It is 
possible that the patients felt fewer symptoms and, therefore, scored an 
improved PCS score for HR-QoL. Tierney et al (16) found that patients with 
HF associated an improvement in physical fitness with well-being and 
maintaining independent living.  
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In study II, no significant difference was found in HR-QoL in patients with 
permanent AF. This was congruent with the study by Risom et al (10), who 
found no evidence that exercise-based CR improves HR-QoL. However, 
another meta-analysis found improvements in some dimensions of SF-36, 
GH and VT, with exercise-based CR (65). As in patients with HF, the degree 
of symptom burden has been associated with low HR-QoL in patients with 
AF (73, 78). Guglin et al (15) found that the prevalence of symptoms in 
patients with AF increases with time in AF until the patient spends almost all 
the time in AF, then the symptom burden seems to decrease. In this study, the 
patients were well medicated and diagnosed with permanent AF. Patients 
with permanent AF have fewer symptoms than patients with non-permanent 
AF (33). These results are congruent with our study, as the patients with 
permanent AF rated their HR-QoL as similar to that of healthy Swedish 
individuals of the same age (110) .  
In this thesis, we chose to use a non-specific generic instrument to measure 
HR-QoL, the SF-36 (108). We are aware of the ability to use a diagnosis-
specific instrument, and there are some instruments for patients with HF or 
AF. However, the use of a generic instrument rather than a disease-specific 
instrument allows us to compare the patients across diseases and with the 
normative population of the same age. It allows us to investigate the patients’ 
preserved health from a perspective apart from disease. Furthermore, a 
disease-specific instrument may not detect unforeseen side effects of the 
target condition (139).  
 Metabolic risk markers 
CR includes, besides PTX and physical activity counselling, other core 
components that also allude to reduce the risk factors for cardio vascular 
disease (40). In study II neither PTX nor PAP reduced blood glucose and 
cholesterol. It must be taken into account that these patients already had 
blood glucose and cholesterol within reference limits at baseline, and 
therefore further improvement in these variables was unexpected.  
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 Detraining 
In study III, a 3-month period of detraining showed that the increment in 
physical fitness achieved by PT-X and the HR-QoL RE score were 
significantly reduced in patients with permanent AF. Other studies have 
found similar effects regarding the effect of detraining on VO2peak and 
muscular strength in patients with CAD and in older adults (140, 141). In this 
study, we wanted to come as close to the clinical reality as possible, and 
although exercise-based CR improves physical fitness, the exercise needs to 
be continued on one’s own accord after the programme is completed. 
Unfortunately, studies in patients with CAD and chronic HF have shown the 
difficulty for patients to continue exercising and be physically active after 
finishing the rehabilitation with PTX (142, 143) or PAP (130, 144). It is also 
difficult to adhere to PT-X, and various regimens have been compared but 
none seem to be effective (145).  
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7 CONCLUSION 
This thesis shows that PT-X improves physical fitness in patients with 
chronic HF and comorbidities and in patients with permanent AF. PT-X is 
also superior over PAP regarding improvement in physical fitness in patients 
with permanent AF. PT-X should therefore be offered as a part of the medical 
treatment.  
PT-X is well tolerated and safe in patients with permanent AF.  
Individually prescribed PAP such as active walking increases energy 
expenditure but not physical fitness in patients with permanent AF.  
Participating in PT-X do not augment the physical activity level in patients 
with chronic HF or in patients with permanent AF.  
PT-X improves HR-QoL in patients with chronic HF but not in patients with 
permanent AF.  
Detraining markedly decreased HR-QoL and reversed the gains in physical 
fitness acquired after 12 weeks of PTX -X in patients with permanent AF. 
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8 FUTURE PERSPECTIVES 
The knowledge of lifestyle management has grown and its importance is now 
mentioned in every guideline regarding chronic HF and all types of AF. This 
raise many further research questions, each of them important for patients 
with cardiac diseases. 
We found that patients with permanent AF improved physical fitness but not 
HR-QoL or metabolic risk markers. These patients were well medicated and 
with similar HR-QoL as the normative population. It would therefore be of 
further interest to investigate the effect of PT-X in patients with paroxysmal 
or persistent AF. These patients are often more symptomatic and the effect of 
PT-X is sparsely investigated.  
To keep up the good habits after cessation from an exercise period is difficult 
either you are a healthy person or living with a chronic disease. Several 
techniques have been tested, but none has been superior over the other. What 
happens in the body organs in patients with chronic HF and AF when you 
stop exercise, and how can we support the patients in the best way? These 
questions require more research to be able to answer. 
Although the evidence for PT-X is high, it is still an underused medical 
treatment. The amount of physiotherapists working within PT-X in Sweden 
and the amount of potential patients with cardiac diseases that should benefit 
from PT-X needs further investigation.
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